medicasolution

Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5.

Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity.

Researchers from Mount Sinai School of Medicine have found a new mechanism that explains how certain immune cells are activated to create protective antibodies against infections or pathological antib

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add 9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin

Arena Pharmaceuticals, Inc.

A study by researchers at NYU Langone Medical Center have found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by M

Northwest Biotherapeutics, Inc.

MannKind Corporation today reported financial results for the second quarter ended June 30, 2010.

A study in the Aug. 1 issue of the journal Sleep suggests that regularly sleeping for more or less than seven hours per day is associated with an increased risk of cardiovascular disease.

Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directo